BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination
Journal of Cell Biology · 2024
DOI: 10.1083/jcb.202310143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Jiajia Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Cell Differentiation, DNA Helicases, Oligodendroglia, Polycomb Repressive Complex 2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Natural Science Foundation of China, National Multiple Sclerosis Society.
Abstract (Originalsprache)
Chromatin-remodeling protein BRG1/SMARCA4 is pivotal for establishing oligodendrocyte (OL) lineage identity. However, its functions for oligodendrocyte-precursor cell (OPC) differentiation within the postnatal brain and during remyelination remain elusive. Here, we demonstrate that Brg1 loss profoundly impairs OPC differentiation in the brain with a comparatively lesser effect in the spinal cord. Moreover, BRG1 is critical for OPC remyelination after injury. Integrative transcriptomic/genomic profiling reveals that BRG1 exhibits a dual role by promoting OPC differentiation networks while repressing OL-inhibitory cues and proneuronal programs. Furthermore, we find that BRG1 interacts with EED/PRC2 polycomb-repressive-complexes to enhance H3K27me3-mediated repression at gene loci associated with OL-differentiation inhibition and neurogenesis. Notably, BRG1 depletion decreases H3K27me3 deposition, leading to the upregulation of BMP/WNT signaling and proneurogenic genes, which suppresses OL programs. Thus, our findings reveal a hitherto unexplored spatiotemporal-specific role of BRG1 for OPC differentiation in the developing CNS and underscore a new insight into BRG1/PRC2-mediated epigenetic regulation that promotes and safeguards OL lineage commitment and differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Division of Developmental Biology, Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
ORCID-Profile: Jiajia Wang, Lijun Yang, Yiwen Du, Jincheng Wang, Qinjie Weng, Xuezhao Liu, Eva Nicholson, Qing Richard Lu
Förderung
- National Natural Science Foundation of China
- National Multiple Sclerosis Society
Zitieren
APA
Wang, J., Yang, L., Du, Y., Wang, J., Weng, Q., Liu, X., Nicholson, E., Xin, M., & Lu, Q. R. (2024). BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination. Journal of Cell Biology. https://doi.org/10.1083/jcb.202310143
Vancouver
Wang J, Yang L, Du Y, Wang J, Weng Q, Liu X, et al. BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination. Journal of Cell Biology. 2024. doi:10.1083/jcb.202310143
BibTeX
@article{Wang2024,
author = {Wang, Jiajia and Yang, Lijun and Du, Yiwen and Wang, Jincheng and Weng, Qinjie and Liu, Xuezhao and Nicholson, Eva and Xin, Mei and Lu, Qing Richard},
title = {BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination},
journal = {Journal of Cell Biology},
year = {2024},
doi = {10.1083/jcb.202310143}
}
EUVIMED